SeaCrest Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.09M Sell
15,546
-497
-3% -$34.7K 0.12% 168
2025
Q1
$1.18M Sell
16,043
-358
-2% -$26.3K 0.13% 151
2024
Q4
$1.07M Sell
16,401
-945
-5% -$61.9K 0.11% 167
2024
Q3
$1.35M Sell
17,346
-168
-1% -$13.1K 0.15% 135
2024
Q2
$1.37M Buy
17,514
+160
+0.9% +$12.5K 0.16% 126
2024
Q1
$1.18M Buy
17,354
+420
+2% +$28.5K 0.14% 153
2023
Q4
$1.16M Buy
16,934
+947
+6% +$64.8K 0.14% 144
2023
Q3
$1.08M Sell
15,987
-245
-2% -$16.6K 0.14% 153
2023
Q2
$1.16M Sell
16,232
-501
-3% -$35.9K 0.15% 145
2023
Q1
$1.16M Sell
16,733
-273
-2% -$18.9K 0.16% 138
2022
Q4
$1.15M Sell
17,006
-180
-1% -$12.2K 0.17% 141
2022
Q3
$942K Buy
17,186
+467
+3% +$25.6K 0.14% 154
2022
Q2
$1.11M Buy
16,719
+737
+5% +$48.7K 0.14% 152
2022
Q1
$1.06M Buy
15,982
+1,915
+14% +$127K 0.12% 182
2021
Q4
$819K Buy
14,067
+419
+3% +$24.4K 0.09% 222
2021
Q3
$820K Buy
13,648
+1,046
+8% +$62.8K 0.1% 217
2021
Q2
$755K Sell
12,602
-279
-2% -$16.7K 0.09% 241
2021
Q1
$640K Sell
12,881
-219
-2% -$10.9K 0.08% 255
2020
Q4
$655K Sell
13,100
-11,599
-47% -$580K 0.09% 237
2020
Q3
$1.35M Buy
24,699
+9,389
+61% +$514K 0.22% 98
2020
Q2
$810K Buy
15,310
+4,361
+40% +$231K 0.14% 166
2020
Q1
$489K Sell
10,949
-220
-2% -$9.83K 0.11% 214
2019
Q4
$557K Sell
11,169
-108
-1% -$5.39K 0.09% 250
2019
Q3
$503K Sell
11,277
-265
-2% -$11.8K 0.09% 260
2019
Q2
$476K Sell
11,542
-513
-4% -$21.2K 0.1% 252
2019
Q1
$487K Sell
12,055
-441
-4% -$17.8K 0.08% 239
2018
Q4
$475K Buy
12,496
+309
+3% +$11.7K 0.1% 212
2018
Q3
$482K Buy
12,187
+275
+2% +$10.9K 0.08% 263
2018
Q2
$418K Buy
11,912
+177
+2% +$6.21K 0.08% 291
2018
Q1
$410K Sell
11,735
-196
-2% -$6.85K 0.08% 290
2017
Q4
$414K Buy
+11,931
New +$414K 0.08% 286